Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 4 [42-168]
Ligand
BDBM362658
Substrate
n/a
Meas. Tech.
BRD4 AlphaScreen Assay
IC50
<25±n/a nM
Citation
 Combs, AP; Sparks, RB Tricyclic heterocycles as bet protein inhibitors US Patent  US10227359 Publication Date 3/12/2019 
Target
Name:
Bromodomain-containing protein 4 [42-168]
Synonyms:
BRD4 | BRD4 BD1 (aa 42-168) | BRD4_HUMAN | Bromodomain-containing protein 4 Bromo Domain 1 | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15054.68
Organism:
Homo sapiens (Human)
Description:
O60885[42-168]
Residue:
127
Sequence:
STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE
  
Inhibitor
Name:
BDBM362658
Synonyms:
N-{1-[(4S)-7-(3,5-dimethylisoxazol-4-yl)- 4-pyridin-2-yl-4,5-dihydroimidazo[1,5,4- de][1,4]benzoxazin-2-yl]piperidin-4- yl}cyclobutanecarboxamide | US10227359, Example 13 | US9834565, Example 13
Type:
Small organic molecule
Emp. Form.:
C29H32N6O3
Mol. Mass.:
512.6028
SMILES:
Cc1noc(C)c1-c1ccc2nc(N3CCC(CC3)NC(=O)C3CCC3)n3C(COc1c23)c1ccccn1 |(.42,-6.55,;1.89,-7.02,;2.36,-8.49,;3.9,-8.49,;4.38,-7.02,;5.84,-6.55,;3.13,-6.12,;3.13,-4.58,;4.47,-3.81,;4.47,-2.27,;3.13,-1.5,;2.57,-.07,;1.03,-.07,;.26,1.27,;-1.28,1.27,;-2.05,2.6,;-1.28,3.94,;.26,3.94,;1.03,2.6,;-2.05,5.27,;-3.59,5.27,;-4.36,3.94,;-4.36,6.6,;-5.84,7,;-5.45,8.49,;-3.96,8.09,;.47,-1.5,;-.87,-2.27,;-.87,-3.81,;.47,-4.58,;1.8,-3.81,;1.8,-2.27,;-2.2,-1.5,;-3.53,-2.27,;-4.87,-1.5,;-4.87,.04,;-3.53,.81,;-2.2,.04,)|
Structure:
Search PDB for entries with ligand similarity: